Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

10.05
Delayed Data
As of May 25
 +0.28 / +2.87%
Today’s Change
1.42
Today|||52-Week Range
10.38
+173.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues175.0K382.0K158.3K31.4M
 
 
 
 
 
Depreciation And Amortization1.3M2.3M3.3M4.7M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses47.5M82.0M82.5M63.7M
 
 
 
 
 
Research And Development23.1M47.3M41.5M31.7M
 
 
 
 
 
Total Operating Expenses48.8M84.3M85.7M68.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-48.6M-83.9M-85.6M-37.0M
 
 
 
 
 
Extraordinary Credit--2.9M5.9M2.2M
 
 
 
 
Extraordinary Charge-10.7M-12.0M-2.4M0.00
 
 
 
 
Pre-Tax Equity Earnings-78.9K0.000.000.00
 
 
Other Expenses23.2K437.1K57.4K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-58.7M-91.9M-81.7M-34.4M
 
 
 
 
 
Income Taxes-5.3K-2.4K-2.4K-2.4K
 
 
 
 
 
Minority Interest-95.2K0.000.000.00
 
 
Net Income-58.6M-91.9M-81.7M-34.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS46.9M57.4M61.1M73.9M
 
 
 
 
 
Shares To Calculate EPS Diluted46.9M57.4M61.1M73.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.25-$1.60-$1.34-$0.47
 
 
 
 
 
EPS Diluted-$1.25-$1.60-$1.34-$0.47